Key Insights

Highlights

Success Rate

96% trial completion (above average)

Research Maturity

67 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.9%

3 terminated out of 155 trials

Success Rate

95.7%

+9.2% vs benchmark

Late-Stage Pipeline

20%

31 trials in Phase 3/4

Results Transparency

15%

10 of 67 completed with results

Key Signals

10 with results96% success

Data Visualizations

Phase Distribution

92Total
Not Applicable (48)
P 1 (3)
P 2 (10)
P 3 (17)
P 4 (14)

Trial Status

Completed67
Unknown45
Recruiting16
Not Yet Recruiting13
Active Not Recruiting5
Withdrawn5

Trial Success Rate

95.7%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (155)

Showing 20 of 20 trials
NCT07706335Not Yet RecruitingPrimary

Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

NCT07684742Phase 4Not Yet Recruiting

Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome

NCT03677466Not ApplicableCompleted

Intramyocardial Haemorrhage in Patients With Primary STEMI

NCT07616024Not ApplicableNot Yet RecruitingPrimary

Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction

NCT07621107Phase 2Not Yet Recruiting

Effect of Guanxinning Tablet on Coronary Microcirculation After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

NCT04743245Not ApplicableTerminated

Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.

NCT06154265Not ApplicableCompleted

Intraoperative Echocardiography in Low-Risk CABG Surgery

NCT05218005Not ApplicableCompleted

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

NCT03439592CompletedPrimary

Analysis of the Microbiota and STEMI

NCT05800951Active Not Recruiting

Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock

NCT06342141Phase 2Active Not RecruitingPrimary

Empagliflozin for No-reflow Phenomenon in PCI for STEMI

NCT06678074Phase 1Active Not RecruitingPrimary

Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

NCT06528821Active Not Recruiting

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS

NCT04829825Completed

The "MyoThrombus" Study

NCT06851325CompletedPrimary

Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes

NCT07436429Recruiting

Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction

NCT05825573Phase 3Active Not Recruiting

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

NCT07354035Not ApplicableNot Yet RecruitingPrimary

The Coronary Sinus Balloon Pump in STEMI

NCT03470441Phase 2Completed

A Study of Acute Myocardial Infarction Using FDY-5301

NCT07293832RecruitingPrimary

Impact of Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction

Scroll to load more

Research Network

Activity Timeline